Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

3 Mutual Funds From the Invesco Portfolio

researchsnappy by researchsnappy
June 11, 2020
in Investment Research
0
3 Mutual Funds From the Invesco Portfolio
400
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

With more than $1,142.5 billion of assets under management (as of May 31, 2020), Invesco Ltd. offers financial solutions through a diverse set of investment vehicles across major equity, fixed income and alternative asset classes.

This top-notch global investment management company caters to a wide range of mutual funds, including equity and fixed-income funds, and domestic and international funds. The company has more than 6,500 investment professionals and employees, and offers financial services worldwide through offices located in 20 countries.

Below we share with you three top-ranked Invesco mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) or #2 (Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds, their Zacks Rank and past performance.

Invesco Oppenheimer Discovery Fund Class A OPOCX aims for capital growth. The fund invests the majority of its assets in common stocks of American companies that its managers consider as having good potential for growth. It mostly focuses on stocks of small-capitalization companies. OPOCX has three-year annualized returns of 17.8%.

OPOCX has an expense ratio of 1.08% compared with the category average of 1.23%.

Invesco Equally-Weighted S&P 500 Fund Class A VADAX invests the majority of its assets in a diversified portfolio of common stocks that are represented on the S&P 500 Index. The fund seeks total return through capital appreciation and current income. VADAX has returned 3.8% in the past three years.

As of the end of March 2020, VADAX held 511 issues, with 0.34% of its assets invested in Regeneron Pharmaceuticals Inc.

Invesco Diversified Dividend Fund Class A LCEAX seeks long-term capital appreciation of current income. The fund invests the majority of its assets in dividend-paying equity securities. It may also invest in securities of non-U.S. companies. LCEAX has returned 0.5% over the past three years.

Meggan M. Walsh is one of the fund managers of LCEAX since 2002.

To view the Zacks Rank and past performance of all Invesco mutual funds, investors can click here to see the complete list of funds.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Get Your Free (LCEAX): Fund Analysis Report
 
Get Your Free (VADAX): Fund Analysis Report
 
Get Your Free (OPOCX): Fund Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Previous Post

Current Market Scenario of Trombones Market Explored in a New Research by 2025

Next Post

Insights into the Condition of Elderly in India

Next Post
Insights into the Condition of Elderly in India

Insights into the Condition of Elderly in India

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com